Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.22.2.2
Accrued Expenses
9 Months Ended
Sep. 30, 2022
Payables and Accruals [Abstract]  
Accrued Expenses

Note 5 – Accrued Expenses

 

Accrued expenses at September 30, 2022 (unaudited) and December 31, 2021 consisted of the following:

 

                 
    September 30,     December 31,  
    2022     2021  
Accrued payroll and related liabilities   $ 7,833,193     $ 7,528,464  
HHS Provider Relief Funds     1,415,549       863,452  
Accrued interest     5,413,828       5,027,459  
Accrued legal expenses and settlements     454,486       632,318  
Medicare overpayment reserve     1,600,000       -  
Other accrued expenses     2,635,432       1,448,242  
Accrued expenses   $ 19,352,488     $ 15,499,935  

 

Payroll and related liabilities at September 30, 2022 and December 31, 2021 included approximately $2.6 million and $2.3 million, respectively, for penalties associated with approximately $4.1 million and $3.9 million of accrued past due payroll taxes as of September 30, 2022 and December 31, 2021, respectively. This liability account at September 30, 2022 and December 31, 2021 is net of employee retention credits totaling $1.5 million and $1.5 million, respectively. Employee retention credits are also discussed in Note 2.

 

As of September 30, 2022 and December 31, 2021, the Company has accrued $1.4 million and $0.9 million, respectively, of HHS Provider Relief Funds. These funds are more fully discussed in Note 2.

 

Accrued interest at September 30, 2022 and December 31, 2021 included accrued interest of $0.1 million and $0.3 million, respectively, on loans made to the Company by Christopher Diamantis, a former member of the Company’s Board of Directors. The loans from Mr. Diamantis are more fully discussed in Note 6.

 

Subsequent to September 30, 2022, the Company’s Big South Fork Medical Center received a communication from its fiscal intermediary stating that its Medicare cost report for the six months ending December 31, 2021 has been accepted and there was an overpayment by the fiscal intermediary as more fully discussed in Notes 1 and 15. As a result of the communication, during the three and nine months ended September, 30, 2022, the Company recorded a $1.6 million reduction in net revenues and a corresponding Medicare overpayment reserve.